Early implementation of treatment with biologic or targeted synthetic DMARDs after methotrexate failure did not prevent the ...

Due to the wide range of symptoms and their severity in shoulder arthritis, researchers are continually exploring new treatments that ... to the brain. While early research involving c-RFA has ...

The use of biologic and targeted therapies for children with juvenile idiopathic arthritis (JIA) surpassed more typical ...

According to the World Health Organisation (WHO), over 350 million people globally suffer from arthritis, and despite ...

Researchers found that while some patients showed gut instability, others with stable microbiomes did not progress to ...

Arthritis is a common acute or chronic condition affecting the joints and surrounding tissues. It’s estimated that roughly 18 ...

A large cross-sectional study revealed that late-onset axial spondyloarthritis diagnosed after 45 years of age may represent a distinct phenotype from early-onset axial spondyloarthritis.

“In people who may develop [rheumatoid arthritis], these antibodies can appear in the blood long before any symptoms, like ...

Findings indicate gut microbiome diversity changes precede rheumatoid arthritis, offering insights into microbial indicators ...

Changes in the gut microbiome before rheumatoid arthritis is developed could provide a window of opportunity for preventative treatments, new research suggests.